Stud Health Technol Inform. 2025 May 15;327:1301-1302. doi: 10.3233/SHTI250610.
ABSTRACT
Assessing healthcare professionals’ (HCPs’) perceptions on the appropriateness, ease of use and reliability of connected digital health technologies can help to understand acceptance and their recommendations to patients/caregivers for personalization of growth hormone (GH) therapy. Two study cases representing different versions of a digital device were used to facilitate expert panel discussions in the UK and France involving 19 paediatric HCPs. Panel members commented that the new functionalities embodied user-friendly technological progression. The evolution of the easypod device should sustain clinical decision support and enhance personalized approaches to care and management of patients receiving GH therapy.
PMID:40380714 | DOI:10.3233/SHTI250610
